Over the past 20 years, we and others developed the fundamentals of transcranial MRI-guided focused ultrasound (TcMRgFUS), a noninvasive technology that will have a profound impact on all aspects of clinical neuroscience. TcMRgFUS is a disruptive technology that can improve upon or replace existing treatments and enable therapies that are not possible today. It is a radical departure from current treatment methods and involves expertise from a broad range of disciplines. While the full potential that ultrasound can have for disorders of the central nervous system is not widely known, the transformational process already begun.
Our aim i s to establish such a program to accelerate and intensify the clinical translation of new TcMRgFUS applications with a proven potential during the lifetime of this grant. Such translation can only happen if the technology is fully-developed, demonstrated to be safe, and implemented in a final form for therapies with major clinical impact. We propose to develop a large-scale, five-year program that will shepherd TcMRgFUS therapies to clinical use for brain cancer. We have developed three projects that can have transform neurosurgery (non-thermal ablation of brain tumors) and neurooncology (targeted drug delivery of chemotherapy to brain metastases). For drug delivery, we will utilize low-energy FUS bursts to temporarily disrupt the blood-brain barrier, which overcomes the major singular limitation of using most drugs in the brain. In one project, we will develop and validate new methods to plan, guide, and evaluate this procedure. In the second, we have developed a plan to move one application of this technology, delivery of anti-cancer agents to breast cancer brain metastases, to the point where it is ready for safety and efficacy clinical trials. Finally, in the third projet, we will combine FUS and a microbubble agent to enable non-thermal ablation, a noninvasive alternative to surgery and radiosurgery. With this method, we can ablate tissue volumes practically anywhere in the brain without using ionizing radiation and without any limits on repeated treatments. At the end of the grant, we aim to have completed the large-scale work needed to move these game-changing TcMRgFUS applications to patients, paving the way to future broad application in treating brain tumors and other disorders in the central nervous system.
Currently-available treatments for diseases and disorders in the central nervous system are often ineffective or have significant side effects. Ultrasound, which can be focused noninvasively to a small volume in the brain, can be used to locally produce a broad range of bio effects that offer completely new therapeutic approaches. This work aims to advance new applications of focused ultrasound that can have a major and disruptive impact: targeted drug delivery via temporary disruption of the blood-brain barrier and non-thermal ultrasound ablation of tumors.
|Arvanitis, Costas D; Askoxylakis, Vasileios; Guo, Yutong et al. (2018) Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood-tumor barrier disruption. Proc Natl Acad Sci U S A 115:E8717-E8726|
|Harary, Maya; Essayed, Walid I; Valdes, Pablo A et al. (2018) Volumetric analysis of magnetic resonance-guided focused ultrasound thalamotomy lesions. Neurosurg Focus 44:E6|
|Todd, Nick; Zhang, Yongzhi; Arcaro, Michael et al. (2018) Focused ultrasound induced opening of the blood-brain barrier disrupts inter-hemispheric resting state functional connectivity in the rat brain. Neuroimage 178:414-422|
|Crake, Calum; Brinker, Spencer T; Coviello, Christian M et al. (2018) A dual-mode hemispherical sparse array for 3D passive acoustic mapping and skull localization within a clinical MRI guided focused ultrasound device. Phys Med Biol 63:065008|
|Brinker, Spencer T; Crake, Calum; Ives, John R et al. (2018) Scalp sensor for simultaneous acoustic emission detection and electroencephalography during transcranial ultrasound. Phys Med Biol 63:155017|
|Sun, Tao; Zhang, Yongzhi; Power, Chanikarn et al. (2017) Closed-loop control of targeted ultrasound drug delivery across the blood-brain/tumor barriers in a rat glioma model. Proc Natl Acad Sci U S A 114:E10281-E10290|
|Arvanitis, Costas D; Crake, Calum; McDannold, Nathan et al. (2017) Passive Acoustic Mapping with the Angular Spectrum Method. IEEE Trans Med Imaging 36:983-993|
|Sai Chun Tang; McDannold, Nathan J; Vaninetti, Michael (2017) A wireless batteryless implantable radiofrequency lesioning device powered by intermediate-range segmented coil transmitter. Conf Proc IEEE Eng Med Biol Soc 2017:1966-1969|
|Taylor, Erik N; Ding, Yao; Zhu, Shan et al. (2017) Association between tumor architecture derived from generalized Q-space MRI and survival in glioblastoma. Oncotarget 8:41815-41826|
|Aryal, Muna; Fischer, Krisztina; Gentile, Caroline et al. (2017) Effects on P-Glycoprotein Expression after Blood-Brain Barrier Disruption Using Focused Ultrasound and Microbubbles. PLoS One 12:e0166061|
Showing the most recent 10 out of 28 publications